Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
April 6th, 2023
Imugene - Nine Clinical Programs to Advance in 2023
Read More
April 6th, 2023
Imricor Focuses on Dedicated iCMR Labs
Read More
April 6th, 2023
Chimeric Therapeutics - Viral Vector Manufacturing Achieved
Read More
April 6th, 2023
Anteris Technologies - Early Feasibility Study to Start Ahead of 1,000 Patient Pivotal Trial
Read More
April 6th, 2023
Aroa Biosurgery - Manufacturing Capacity to Reach NZ$150 Million
Read More
March 17th, 2023
From Benchtop to the Clinic - Stunning Success for Neuren Pharmaceuticals
Read More
February 24th, 2023
Pharmaxis: A Re-Rating Approaching?
Read More
February 24th, 2023
Opthea - Full Recruitment to Trigger Results Countdown
Read More
February 24th, 2023
Neuren Pharmaceuticals - FDA Decision on Trofinetide Approaching
Read More
February 24th, 2023
EBR Systems - Pivotal Results Due Q2
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
